| Document |
Document Title |
|
WO/2024/091894A1 |
The present disclosure is directed to novel PNU Anthracycline Derivatives of formula (I): and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined in the above disclosure. The disclosure is also directed to pharmac...
|
|
WO/2024/087262A1 |
The present invention relates to the technical field of preparation and use of catalysts, and in particular relates to a preparation method for and the use of a noble metal loaded molecular sieve type bifunctional catalyst. The preparati...
|
|
WO/2024/088307A1 |
Disclosed are a novel peptidyl nitrile compound and a use thereof, and specifically disclosed are a compound of formula (I) and/or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound and/or th...
|
|
WO/2024/091664A1 |
This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain examples, modulators are derivatives of hexahydropental ene. In certain examples, this...
|
|
WO/2024/071620A1 |
Disclosed herein is a process for removing residual hydrogen present in aromatic fractions by reaction with olefins and/or bicyclic aromatic components also contained therein, wherein bromine indices in the aromatic fractions are reduced...
|
|
WO/2024/073155A1 |
A composition comprising a hydrogel includes a polymer of formula (1), at least one repeating unit of which comprises norbomene. Methods of treating wounds and methods of encapsulating drugs and/or cells using such hydrogels are also dis...
|
|
WO/2024/071250A1 |
This diamondoid compound is a new compound represented by general formula (1) [in the formula, ring A1 represents an aliphatic ring having two or more rings, R1 represents a hydrogen atom, an alkyl group, a cycloalkyl group, or an adaman...
|
|
WO/2024/061948A1 |
The present invention relates to nitrogen-containing heterocycles that are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing these heterocycles.
|
|
WO/2024/061942A1 |
The present invention relates to nitrogen-containing compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
|
|
WO/2024/058239A1 |
Provided are: a hole transporting material or an electron blocking material for a photoelectric conversion element for an imaging element including a perylene-based condensed ring compound which can function as a hole transporting materi...
|
|
WO/2024/054738A1 |
Methods and systems for extracting additional beneficial lipid-soluble heavy compounds from plant material in an environmentally sustainable manner. A method includes preparing a solution that includes a solvent comprising an essential o...
|
|
WO/2024/041995A1 |
Ultra-low loss curable hydrocarbon resin compositions comprising vinylbenzyl compounds, a method for the preparation thereof and their use for the manufacture of articles which find application in the electric/electronic industries.
|
|
WO/2024/031877A1 |
The present invention relates to a method for synthesizing cyclopentadiene by means of a biomass platform compound cyclopentanone. Cyclopentanone is used as a starting material, and in a fixed bed continuous reactor and under the action ...
|
|
WO/2024/031876A1 |
The present invention relates to a method for one-step synthesis of methylcyclopentadiene from cyclopentanone and methanol. Cyclopentanone and methanol are used as raw materials, and are subjected to a cascade dehydrogenation/aldol conde...
|
|
WO/2024/030736A1 |
Processes and facilities for producing several types of recycled content organic chemical compounds from waste plastic. Processing schemes are described herein for converting waste plastic (or hydrocarbon having recycled content derived ...
|
|
WO/2024/029418A1 |
The present invention provides a method for producing a cycloolefin by causing a partial hydrogenation reaction of a monocyclic aromatic hydrocarbon by means of hydrogen in the presence of a ruthenium catalyst in an aqueous zinc sulfate ...
|
|
WO/2024/029292A1 |
The purpose of the present invention is to provide a method for manufacturing a semiconductor substrate using a composition capable of forming a film having excellent etching resistance; and to provide said composition. The composition a...
|
|
WO/2024/028516A1 |
A synthesis method for the preparation of a cannabinoid selected from cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), comprising the steps of: a) dissolving olivetol in dichloromethane (DCM) with stirring; b) adding FeCl3 * 6H2O as...
|
|
WO/2024/030521A1 |
Provided herein is a copper-free, non-toxic click hydrogel that exhibits minimal swelling and derived from dibenzocyclooctyne maleimide, poly-ethylene glycol dithiol and azide acrylate. The hydrogel may be used as a sealant and/or as a d...
|
|
WO/2024/012470A1 |
The present invention provides a use of an adamantane nitrate compound or a pharmaceutically acceptable salt thereof in preparation of a drug and in prevention and treatment of cytokine storm. It is found in experiments that the adamanta...
|
|
WO/2024/015384A1 |
The disclosure provides an improved method for preparing monoalkylated cyclopentadiene species in high yield and selectivity. In the process, either a solution of dicyclopentadiene magnesium or a cyclopentadiene magnesium halide is react...
|
|
WO/2024/014365A1 |
A fuel cell module according to the present invention comprises a container, a fuel cell, a combustion unit and a first reactor. The fuel cell supplies an unreacted fuel to the combustion unit through a channel for an exhaust gas that co...
|
|
WO/2024/010772A1 |
Disclosed herein are small molecule compounds that are capable of inhibiting NLRP3 family proteins and NLRP3 inflammasome function in various disease settings. The disease is characterized by a disease progression pathology that comprise...
|
|
WO/2024/001986A1 |
Disclosed is a continuous method for producing adamantane, comprising the following steps: 1) providing a liquid feed stream comprising endo-tetrahydrodicyclopentadiene; and 2) enabling the liquid feed stream to sequentially pass through...
|
|
WO/2023/245790A1 |
The present invention relates to a method for preparing a cycloalkane from a cyclic alcohol in one step by means of a molecular sieve. The method for preparing a cycloalkane is characterized by comprising: in an inert gas atmosphere, add...
|
|
WO/2023/240364A1 |
Homogeneous extract-infused cannabis biomasses, methods for their preparation, and products produced therefrom, such as pre-rolled joints, are provided. An exemplary method comprises steps of providing a cannabis extract; heating the can...
|
|
WO/2023/240380A1 |
An endothermic liquid hydrocarbon fuel, the endothermic liquid hydrocarbon fuel comprising the following materials: 2-(2-cyclopropyl-vinyl)-adamantane, adamantylideneadamantane, shale oil, carbon monoxide, a cycloalkane, an aromatic hydr...
|
|
WO/2023/239193A1 |
The present invention provides a novel compound and an organic light-emitting device using same.
|
|
WO/2023/238629A1 |
The present disclosure provides an organic compound characterized by being represented by general formula [1]. In general formula [1], Ar1 and Ar2 are each independently selected from among an aryl group and a heterocyclic group. Ar1 and...
|
|
WO/2023/223692A1 |
A nonlinear absorbing material in one aspect of the present disclosure includes a compound represented by the following formula (1). In formula (1), R1 to R12, independently of each other, represent groups containing at least one atom se...
|
|
WO/2023/199851A1 |
Provided are: a semiconductor substrate manufacturing method using a resist underlayer film-forming composition from which it is possible to form a film having excellent etching resistance, heat resistance, and bending resistance; a comp...
|
|
WO/2023/154412A9 |
Pharmaceutical compounds have anti-inflammatory activity and are capable of reducing the levels of substance P(SP), calcitonin gene-related peptide (CGRP), glutamate, or a combination thereof. A pharmaceutical composition may include a t...
|
|
WO/2023/196193A1 |
This disclosure relates to a one-step process for making BCI. The process involves contacting a starting material comprising MCDDK with hydrogen in the presence of a catalyst mixture in a reaction zone to produce a product mixture compri...
|
|
WO/2023/186881A1 |
The invention relates to p38 MAP kinase inhibitors of formula (I) as shown in the description for use in the treatment of colorectal cancer. Further, the invention relates to p38 MAP kinase inhibitors specifically mentioned in the descri...
|
|
WO/2023/192814A1 |
The present disclosure encompasses novel benzamide enaminone compounds and pharmaceutically acceptable salts thereof and compositions including such compounds and pharmaceutically acceptable salts. The disclosure further encompasses meth...
|
|
WO/2023/192847A1 |
Polymerization inhibitor compositions are provided. The polymerization inhibitor compositions include at least a first inhibitor compound including a hydroxylamine, a second inhibitor including phenylenediamine, and a third inhibitor inc...
|
|
WO/2023/192868A1 |
Inhibitor compositions for abating undesirable polymerization in the vapor space during purification of reactive vinylic monomers are provided. The polymerization inhibitor compositions include at least a first inhibitor compound having ...
|
|
WO/2023/183285A1 |
This disclosure provides compounds, pharmaceutical compositions, imaging compositions and methods useful for the diagnosis and/or treatment of neurodegenerative diseases. In particular, this disclosure provides compounds, including radio...
|
|
WO/2023/177143A1 |
The present disclosure describes a technology that uses a mixture of monobenzyltoluene isomers of controlled composition as a liquid organic hydrogen carrier on the basis of the properties of individual structural isomers (ortho-, meta-,...
|
|
WO/2023/160035A1 |
A β-elemene vinylation coupled derivative, and a preparation method therefor and the use thereof in the preparation of an antitumor drug. Provided are a β-elemene vinylation coupled derivative having a structure as represented by formu...
|
|
WO/2023/155248A1 |
Provided are an amphiphilic monodisperse polymer containing a fluorene-butadiene structure in a main chain, nanofibers and a preparation method. Azidated polyethylene glycol is reacted with a fluorene-butadiene copolymer to obtain an amp...
|
|
WO/2023/140986A1 |
Compositions containing tri-cyclopentadiene and processes for making same. In some embodiments, the composition can include 1 wt% to 6 wt% of TCPD-7; 5 wt% to 25 wt% of TCPD-3; 15 wt% to 30 wt% of TCPD-5; and 55 wt% to 75 wt% of TCPD-1, ...
|
|
WO/2023/139627A1 |
There is provided a pharmaceutical composition including a compound of the general formula (I) or a pharmaceutically acceptable salt thereof, and atleast one pharmaceutically acceptable carrier for treatment of cancer. The prepared pharm...
|
|
WO/2023/131667A1 |
Embodiments of the invention are directed to cooling compounds and cooling compositions having a unique cooling perception, as well as various edible, potable, and/or cosmetic products containing one or more cooling compounds having a ge...
|
|
WO/2023/132366A1 |
Provided is a cyclopentene recovery method for recovering cyclopentene by causing a metathesis catalyst to act on a ring‐opened polymer having a structural unit derived from cyclopentene.
|
|
WO/2023/128638A1 |
The present invention relates to an anthracene derivative compound having a characteristic structure in which an aliphatic aromatic mixed ring group is substituted, and to an organic light-emitting device comprising same. The present inv...
|
|
WO/2023/129909A1 |
Provided herein are compounds of Formula (I), (I-A), (I-B), (II), (II-A), (II-B), (III), (III-A), (IV), and (IV-A), or pharmaceutically acceptable salt thereof described herein. Also provided herein are pharmaceutical compositions compri...
|
|
WO/2023/128467A1 |
The present invention relates to a hydrogen storage material using a naphthalene-based derivative and a manufacturing method therefor, and more specifically, provides a hydrogen storage material containing a methylbenzyl naphthalene isom...
|
|
WO/2023/120152A1 |
Provided are: a diamantane compound that makes it possible to produce an organic electroluminescence element that achieves excellent light-emission efficiency characteristics or, more preferably, excellent drive voltage characteristics a...
|
|
WO/2023/104159A1 |
The present invention relates to compounds as calcium channel blocker, a composition comprising thereof, use of said compounds and a method for treating diseases or disorders associated with calcium ion channel using said compounds. The ...
|
